News

Back

Ncardia launches Cellistic, an iPSC cell therapy CDMO

April 19th 2022

BSCB Dev

Ncardia launches CellisticTM, the only iPSC-based cell therapy process development & manufacturing partner purpose-built to make large-scale allogeneic cell therapy production a reality today.

Read Pdf